+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Does use of pooled cohort risk score overestimate the use of statin?: a retrospective cohort study in a primary care setting

Does use of pooled cohort risk score overestimate the use of statin?: a retrospective cohort study in a primary care setting

Bmc Family Practice 15: 172

Initiation of statin therapy as primary prevention particularly in those with mildly elevated cardiovascular disease risk factors is still being debated. The 2013 ACC/AHA blood cholesterol guideline recommends initiation of statin by estimating the 10-year atherosclerotic cardiovascular disease (ASCVD) risk using the new pooled cohort risk score. This paper examines the use of the pooled cohort risk score and compares it to actual use of statins in daily clinical practice in a primary care setting. We examined the use of statins in a randomly selected sample of patients in a primary care clinic. The demographic data and cardiovascular risk parameters were captured from patient records in 1998. The pooled cohort risk score was calculated based on the parameters in 1998. The use of statins in 1998 and 2007, a 10-year interval, was recorded. A total of 847 patients were entered into the analysis. Mean age of the patients was 57.2 ± 8.4 years and 33.1% were male. The use of statins in 1998 was only 10.2% (n = 86) as compared to 67.5% (n = 572) in 2007. For patients with LDL 70-189 mg/dl and estimated 10-year ASCVD risk ≥7.5% (n = 190), 60% (n = 114) of patients were on statin therapy by 2007. There were 124 patients in whom statin therapy was not recommended according to ACC/AHA guideline but were actually receiving statin therapy. An extra 40% of patients need to be treated with statin if the 2013 ACC/AHA blood cholesterol guideline is used. However the absolute number of patients who needed to be treated based on the ACC/AHA guideline is lower than the number of patients actually receiving it in a daily clinical practice. The pooled cohort risk score does not increase the absolute number of patients who are actually treated with statins. However these findings and the use of the pooled cohort risk score need to be validated further.

(PDF emailed within 0-6 h: $19.90)

Accession: 052696597

Download citation: RISBibTeXText

PMID: 25388219

DOI: 10.1186/s12875-014-0172-y

Related references

Validation of the pooled cohort risk score in an Asian population - a retrospective cohort study. Bmc Cardiovascular Disorders 14: 163, 2015

Comparison on Statin Use among Hypertensive Patients between Framingham Risk Score and Pooled Cohort Risk Score. Journal of Hypertension 33: E26-E27, 2015

Validating the Electronic Cardiac Arrest Risk Triage (eCART) Score for Risk Stratification of Surgical Inpatients in the Postoperative Setting: Retrospective Cohort Study. Annals of Surgery 2018, 2018

Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations. Lancet. Haematology 2019, 2019

Accuracy of Pooled-Cohort Equation and SCORE cardiovascular risk calculators to identify individuals with high coronary atherosclerotic burden - implications for statin treatment. Coronary Artery Disease 27(7): 573-579, 2017

Statin therapy and gastrointestinal hemorrhage: a retrospective cohort study with propensity score-matching. Pharmacoepidemiology and Drug Safety 24(8): 849-857, 2016

Quality of Care for Patients With Chronic Kidney Disease in the Primary Care Setting: A Retrospective Cohort Study From Ontario, Canada. Canadian Journal of Kidney Health and Disease 4: 2054358117703059, 2017

Quality of care and volume for patients with diabetes mellitus in the primary care setting: A population based retrospective cohort study. Diabetes Research and Clinical Practice 120: 171-181, 2016

Trends in HIV testing and recording of HIV status in the UK primary care setting: a retrospective cohort study 1995-2005. Sexually Transmitted Infections 85(7): 520-526, 2010

Hypertension and the development of new onset chronic kidney disease over a 10 year period: a retrospective cohort study in a primary care setting in Malaysia. Bmc Nephrology 13: 173-173, 2013

Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study. Copd 11(5): 521-530, 2015

Resource Use and Costs up to Two Years Post Diagnosis Among Newly Diagnosed COPD Patients in the UK Primary Care Setting: A Retrospective Cohort Study. Copd 12(3): 267-275, 2016

Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study. Bmj 346: F2573-F2573, 2013

Depression, vascular factors, and risk of dementia in primary care: a retrospective cohort study. Journal of the American Geriatrics Society 63(4): 692-698, 2015

Cohort study investigating the relationship between cholesterol, cardiovascular risk score and the prescribing of statins in UK primary care: study protocol. Bmj Open 6(11): E013120, 2017